| # | Drug | Count |
|---|---|---|
| 0 | SOFOSBUVIR | 223 |
| 1 | RIBAVIRIN | 180 |
| 2 | TENOFOVIR DISOPROXIL FUMARATE | 137 |
| 3 | LEDIPASVIR AND SOFOSBUVIR | 112 |
| 4 | LAMIVUDINE | 104 |
| 5 | LAMIVUDINE ORAL | 95 |
| 6 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 83 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 78 |
| 8 | RITONAVIR | 73 |
| 9 | VELPATASVIR AND SOFOSBUVIR | 72 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ABACAVIR , LAMIVUDINE AND ZIDOVUDINE | 1 | 0.1000 |
| 1 | ADEFOVIR DIPIVOXIL | 41 | 0.0323 |
| 2 | IBALIZUMAB | 11 | 0.0204 |
| 3 | SOFOSBUVIR | 223 | 0.0114 |
| 4 | RALTEGRAVIR | 55 | 0.0105 |
| 5 | DORAVIRINE | 8 | 0.0102 |
| 6 | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | 11 | 0.0101 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 78 | 0.0090 |
| 8 | LEDIPASVIR AND SOFOSBUVIR | 112 | 0.0059 |
| 9 | VELPATASVIR AND SOFOSBUVIR | 72 | 0.0056 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD4-directed Blocking Antibody [EPC] | 11 | 0.0204 |
| 1 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 404 | 0.0077 |
| 2 | Hepatitis C Virus NS5A Inhibitor [EPC] | 202 | 0.0042 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 97 | 0.0040 |
| 4 | CCR5 Co-receptor Antagonist [EPC] | 9 | 0.0039 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 329 | 0.0030 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 136 | 0.0028 |
| 7 | Nucleoside Analog Antiviral [EPC] | 183 | 0.0021 |
| 8 | Protease Inhibitor [EPC] | 90 | 0.0020 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 116 | 0.0019 |